Bernadette Corront

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Christian Récher, Bertrand Coiffier, Corinne Haïoun et al. · The Lancet · 2011 · 357 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Catherine Thiéblemont, Hervé Tilly, María Gomes da Silva et al. · Journal of Clinical Oncology · 2017 · 195 citations

Medicine, Oncology, Pharmacotherapy +14

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

Laëtitia Vercellino, Anne‐Ségolène Cottereau, Olivier Casasnovas et al. · Blood · 2020 · 185 citations · Full text

Medicine, Cancer Biology, Oncology +12

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study

Michaël Loschi, Raphaël Porcher, Fiorenza Barraco et al. · American Journal of Hematology · 2015 · 141 citations · Full text

Medicine, Hematology, Clinical Pharmacology +7

Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?

Hervé Avet‐Loiseau, Florent Malard, L. Campion et al. · Blood · 2010 · 127 citations · Full text

Medicine, Hematology, Oncology +14